Screener
Madrigal Pharmaceuticals, Inc. MDGL Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, par value $0.0001 per share authorized: 5,000,000 shares at June 30, 2026 and December 31, 2025; 2,369,797 shares issued and outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, par value $0.0001 per share authorized: 200,000,000 shares at June 30, 2026 and December 31, 2025; 23,093,974 and 22,842,073 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 2 | 2 |
| Additional paid-in-capital | 2,765,710 | 2,692,280 |
| Accumulated other comprehensive income | 808 | 873 |
| Accumulated deficit | (2,242,796) | (2,090,466) |
| Total stockholders’ equity | 523,724 | 602,689 |
| Total liabilities and stockholders’ equity | $1,244,645 | $1,259,589 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s retained earnings?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported retained earnings of -$2.24B in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s retained earnings changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s retained earnings decreased by 17.0% year-over-year, from -$1.92B to -$2.24B.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s retained earnings has grown at a 37.5% compound annual growth rate (CAGR), from -$425.46M to -$2.09B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude